alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.1**
**CERTIFICATIONS**
I, Ian G. Cockwell, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Brookfield HomesCorporation; 2. Based on my knowledge, this report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by thisreport; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a – 15(e) and 15d – 15(e)) for theregistrant and have:
 (a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known tous by others within those entities, particularly during the period inwhich this report is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the endof the period covered by this report based on such evaluation; and  (c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’smost recent fiscal quarter that has materially affected, or isreasonably likely to materially affect, the registrant’s internalcontrol over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based onour most recent evaluation of internal control over financial reporting,to the registrant’s auditors and the audit committee of the registrant’sboard of directors (or persons performing the equivalent functions):
 (a) All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability torecord, process, summarize and report financial information; and  (b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’sinternal control over financial reporting.   Date: August 9, 2004   By: /s/ IAN G. COCKWELL   Ian G. Cockwell President and Chief Executive Officer
#### The People of the State of New York, Respondent, v Mazin Assi, Appellant.

Submitted July 13, 2009;

decided August 27, 2009

Reported below, 63 AD3d 19.

Motion for assignment of counsel granted and Robert S. Dean, Esq., Center for Appellate Litigation, 74 Trinity Place, 11th Floor, New York, NY 10006 assigned as counsel to the appellant on the appeal herein.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       1,571,765
<SECURITIES>                                         0
<RECEIVABLES>                                  193,204
<ALLOWANCES>                                         0
<INVENTORY>                                    204,598
<CURRENT-ASSETS>                             2,091,344
<PP&E>                                         536,844
<DEPRECIATION>                                 227,620
<TOTAL-ASSETS>                               3,405,476
<CURRENT-LIABILITIES>                        1,052,746
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        66,036
<OTHER-SE>                                   4,282,297
<TOTAL-LIABILITY-AND-EQUITY>                 3,405,476
<SALES>                                        714,462
<TOTAL-REVENUES>                               714,462
<CGS>                                        1,575,690
<TOTAL-COSTS>                                (861,228)
<OTHER-EXPENSES>                             1,939,871
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              51,211
<INCOME-PRETAX>                            (2,917,338)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,917,338)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,917,338)
<EPS-PRIMARY>                                    (.58)
<EPS-DILUTED>                                    (.58)
        

</TABLE>
#### State v. Hurley

Case below: 180 N.C. App. 680

No. 038P07

Def’s PDR Under N.C.G.S. § 7A-31 (COA06-329)

Denied 06/27/07
EX-31 Rule 13a-14(d)/15d-14(d) Certification.


  I, Kristen Ann Cronin, certify that:

  1.I have reviewed this report on Form 10-K and all reports on Form 10-D
    required to be filed in respect of the period covered by this report on
    Form 10-K of Deutsche Alt-A Securities Mortgage Loan Trust, Series
    2007-AR2 (the "Exchange Act periodic reports");

  2.Based on my knowledge, the Exchange Act periodic reports, taken as a
    whole, do not contain any untrue statement of a material fact or omit
    to state a material fact necessary to make the statements made, in
    light of the circumstances under which such statements were made, not
    misleading with respect to the period covered by this report;

  3.Based on my knowledge, all of the distribution, servicing and other
    information required to be provided under Form 10-D for the period
    covered by this report is included in the Exchange Act periodic reports;

  4.I am responsible for reviewing the activities performed by the
    servicer(s) and based on my knowledge and the compliance review(s)
    conducted in preparing the servicer compliance statement(s) required in
    this report under Item 1123 of Regulation AB, and except as disclosed
    in the Exchange Act periodic reports, the servicer(s) have fulfilled
    their obligations under the servicing agreement(s) in all material
    respects; and

  5.All of the reports on assessment of compliance with servicing criteria
    for asset-backed securities and their related attestation reports on
    assessment of compliance with servicing criteria for asset-backed
    securities required to be included in this report in accordance with
    Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18
    have been included as an exhibit to this report, except as otherwise
    disclosed in this report.  Any material instances of noncompliance
    described in such reports have been disclosed in this report on Form
    10-K.

    In giving the certifications above, I have reasonably relied on
    information provided to me by the following unaffiliated parties:
    Countrywide Home Loans Servicing LP as Servicer , GMAC Mortgage, LLC
    f/k/a GMAC Mortgage Corporation as Servicer, GreenPoint Mortgage
    Funding, Inc. as Servicer, and IndyMac Bank, F.S.B. as Servicer.

    Dated:   March 27, 2008


    /s/ Kristen Ann Cronin
    Signature

    Vice President
    (senior officer in charge of the servicing function of the master
    servicer)
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2500 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 2500

  To amend the Federal Food, Drug, and Cosmetic Act to expand certain 
  authorities with respect to the recall of controlled substances to 
        apply with respect to all drugs, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 6, 2023

Mr. Kim of New Jersey introduced the following bill; which was referred 
                to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To amend the Federal Food, Drug, and Cosmetic Act to expand certain 
  authorities with respect to the recall of controlled substances to 
        apply with respect to all drugs, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Americans from Unsafe 
Drugs Act of 2023''.

SEC. 2. NOTIFICATION, NONDISTRIBUTION, AND RECALL OF DRUGS.

    (a) Order To Cease Distribution and Recall.--Section 569D of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-8d) is amended--
            (1) in the section heading, by striking ``controlled 
        substances'' and inserting ``drugs'';
            (2) by striking ``controlled substance'' each place such 
        term appears and inserting ``drug'';
            (3) in subsection (b)--
                    (A) by striking ``controlled substances'' and 
                inserting ``drugs''; and
                    (B) by inserting ``of subsection (a)'' after ``an 
                order pursuant to paragraph (1) or an amended order 
                pursuant to subparagraph (B) or (C) of paragraph (3)''; 
                and
            (4) in subsection (c), by striking ``or an official senior 
        to such Director'' and inserting ``or the Director of the 
        Center for Biologics Evaluation and Research (or an official 
        senior to either such Director)''.
    (b) Imports and Exports.--Section 801(a) of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 381(a)) is amended by striking ``is a 
controlled substance subject to an order under section 569D'' and 
inserting ``is a drug subject to an order under section 569D''.
                                 <all>
```
FORM
        OF

      ALLONGE
        TO 

      PROMISORY
        NOTE DATED _______ __, 2007

      


      This
        Allonge is hereby attached to and made a part of the Promissory Note dated
        _________ __, 2007 (the “Note”),
        executed by WaferGen, Inc. (“Payor”),
        in
        the original maximum principal amount of $_________, in favor of Alnoor Shivji
        (“Holder”).
        The
        Note is hereby amended as follows

       

      
        	 	
                1.

              	
                The
                  first paragraph of the Note is amended by deleting “March 30, 2007” in the
                  first line and replacing it with “April 30,
                  2007”.

              


      

       

      IN
        WITNESS WHEREOF, Payor and Holder have caused this Allonge to be duly executed
        and delivered as of March 30, 2007.

       

      


      
        	
                PAYOR:
                  

                 

                WAFERGEN,
                  INC.

                 

                 

                By:
                  ______________________________

                Name:
                  

                Title:

              	
                HOLDER:

                 

                 

                 

                 

                __________________________________

                Name:
                  Alnoor Shivji
#### State v. Crump

Case below: 181 N.C. App. 150

No. 058P07

1. Def’s PDR Under N.C.G.S. § 7A-31 (COA06-411)

2. Def s Motion for Affidavit to be Considered with Petition for Discretionary Review

1. Denied 06/27/07

2. Denied 06/27/07
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Larry Sostad, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual
Report on Form 10-KSB of Royal Blue Exploration, Inc., for the fiscal year ended
September 30, 2007 fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 and that the information contained
in the Annual Report on Form 10-KSB fairly presents in all material respects the
financial condition and results of operations of Royal Blue Exploration, Inc.

Date: December 20, 2007

                                           /s/ Larry Sostad
                                           --------------------------------
                                           Larry Sostad
                                           President, C.E.O. and Director
                                           (Principal Executive Officer)
<PAGE>

                                    FORM 6-K
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                        Report of Foreign Private Issuer


                        PURSUANT TO RULE 13a-16 OR 15d-16
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                                JANUARY 18, 2005

                         Commission File Number: 0-22346

                                 HOLLINGER INC.
                 (Translation of registrant's name into English)

                                10 TORONTO STREET
                            TORONTO, ONTARIO M5C 2B7
                                     CANADA
                    (Address of principal executive offices)

    Indicate by check mark whether the registrant files or will file annual
                  reports under cover Form 20-F or Form 40-F.

                         Form 20-F [X]    Form 40-F [ ]

  Indicate by check mark if the registrant is submitting the Form 6-K in paper
          as permitted by Regulation S-T Rule 101(b)(1): ____________

  Indicate by check mark if the registrant is submitting the Form 6-K in paper
          as permitted by Regulation S-T Rule 101(b)(7): ____________

     Indicate by check mark whether by furnishing the information contained
 in this Form, the registrant is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

                              Yes [ ]    No [X]

       If "Yes" is marked, indicate below the file number assigned to the
         registrant in connection with Rule 12g3-2(b): 82- ____________


<PAGE>

                                  EXHIBIT LIST

<TABLE>
<CAPTION>

Exhibit       Description
-------       -----------
<S>           <C>
99.1          Press Release, dated January 14, 2005, regarding Hollinger Inc.
              to Escrow Certain Funds from Telegraph Group Proceeds.
</TABLE>

<PAGE>


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

Date:  January 18, 2005

                                        HOLLINGER INC.

                                        By /s/ Peter G. White
                                           -------------------------------------
                                           Name: Peter G. White
                                           Title: Vice President, Operations
                                                  and Secretary
**EXHIBIT 31.2**
**CERTIFICATIONS**
I, Paul G. Kerrigan, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Brookfield HomesCorporation; 2. Based on my knowledge, this report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by thisreport; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a – 15(e) and 15d – 15(e)) for theregistrant and have:
 (a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known tous by others within those entities, particularly during the period inwhich this report is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the endof the period covered by this report based on such evaluation; and  (c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’smost recent fiscal quarter that has materially affected, or isreasonably likely to materially affect, the registrant’s internalcontrol over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based onour most recent evaluation of internal control over financial reporting,to the registrant’s auditors and the audit committee of the registrant’sboard of directors (or persons performing the equivalent functions):
 (a) All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability torecord, process, summarize and report financial information; and  (b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’sinternal control over financial reporting.   Date: August 9, 2004   By: /s/ PAUL G. KERRIGAN   Paul G. Kerrigan Executive Vice President, Chief Financial Officer and Treasurer
EXHIBIT 13.1



CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002



The certification
set forth below is being submitted in connection with the Annual Report on Form 20-F for the fiscal year ended December 31, 2017
(the “Report”) for the purposes of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities and Exchange Act
of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.



I, Sandro Rogério
da Silva Gamba, Chief Executive Officer of Gafisa S.A., certify that, to the best of my knowledge:



| | · | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934; and
| | - | ---------------------------------------------------------------------------------------------------------------------



| | · | the information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------



Date: April 27, 2018



|GAFISA S.A.
|-----------
|           
|           
|By:        
|           
|
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                            <C>                     <C>
<PERIOD-TYPE>                                3-MOS                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1997             JUN-30-1996
<PERIOD-END>                               SEP-30-1996             JUN-30-1996
<CASH>                                         109,254                 102,223
<SECURITIES>                                    10,035<F2>               4,923
<RECEIVABLES>                                   47,280                  61,245
<ALLOWANCES>                                         0                       0
<INVENTORY>                                    149,622<F1>             221,866
<CURRENT-ASSETS>                               316,191                 390,257
<PP&E>                                       1,543,527               1,495,134
<DEPRECIATION>                               1,001,342                 968,315
<TOTAL-ASSETS>                               1,182,587               1,196,849
<CURRENT-LIABILITIES>                          468,336                 345,229
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                        5,651,388<F3>           5,651,388
<PREFERRED>                                          0                       0
<COMMON>                                        22,124                  22,124
<OTHER-SE>                                 (4,912,507)<F4>           4,775,138
<TOTAL-LIABILITY-AND-EQUITY>                 1,182,587               1,196,849
<SALES>                                         76,057                 336,174
<TOTAL-REVENUES>                                80,297                 387,442
<CGS>                                            9,086                   7,046
<TOTAL-COSTS>                                  217,666                 172,000
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                              (137,369)                 215,442
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 (137,369)                 215,442
<EPS-PRIMARY>                                    (.03)                   (.05)
<EPS-DILUTED>                                    (.03)                   (.05)
<FN>
<F2>PrePaid Expense
<F1>Precious Metals
<F3>Capital in Excess of Par
<F4>Retained Earnings
</FN>
        

</TABLE>
EXHIBIT 13.1
   CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002
  The certification set forth below is being submitted in connection with the Annual Report on Form 20-F/Afor the fiscal year ended December 31, 2009 (the “Report”) for the purposes of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities and Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
  I, Alceu Duílio Calciolari,Chief Executive Officer of Gafisa S.A., certify that, to the best of my knowledge:
  ·
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  ·
the information contained in the Report fairly presents, in all material respects, the financial condition andresults of operations of the Company.
  Date: July 5, 2012
  By:
/s/ Alceu Duílio CalciolariName:    Alceu Duílio CalciolariTitle:     Chief Executive Officer